Browse Related Topics For:

Off-Label Use

80
Pharmaceutical Industry
66
FDA
60
Off-Label Promotion
37
First Amendment
37
Prescription Drugs
36
FDCA
32
Free Speech
22
Commercial Speech
21
Medical Devices
20
Marketing
15
Amarin
15
False Claims Act (FCA)
14
Misbranding
11
DOJ
10
Healthcare
9
Failure To Warn
9
FDA Approval
8
Preemption
7
Qui Tam
6
Popular
6
Preliminary Injunctions
6
Whistleblowers
5
Caronia
5
Fraud
5
Medicare
5
Negligence
5
Physicians
4
Birth Defects
4
Compliance
4
Criminal Prosecution
4
False Advertising
4
First-to-File
4
FTC
4
GlaxoSmithKline
4
Manufacturers
4
Product Defects
4
Product Labels
3
Advertising
3
Breach of Warranty
3
Corporate Counsel
3
Dismissals
3
FDA Warning Letters
3
Financial Conduct Authority (FCA)
3
Generic Drugs
3
Health Care Providers
3
Hospitals
3
Labeling
3
Medtronic
3
Misrepresentation
3
Patents
3
Pleading Standards
3
Relators
3
SCOTUS
2
Abbott Laboratories
2
Appeals
2
Bristol-Myers Squibb
2
Causation
2
Choice-of-Law
2
Class Action
2
Clinical Trials
2
CMS
2
Comment Period
2
Declaratory Relief
2
Dietary Supplements
2
Due Process
2
Enforcement Actions
2
EU
2
Expert Testimony
2
Expert Witness
2
Federal Register
2
Fines
2
Fraudulent Concealment
2
FTC Act
2
Healthcare Fraud
2
HHS
2
Injunctive Relief
2
Innovator Liability
2
InterMune
2
Johnson & Johnson
2
Lanham Act
2
Life Sciences
2
Medicaid
2
Medical Research
2
Medicare Part D
2
Misleading Statements
2
Novartis
2
Orphan Drugs
2
Proposed Regulation
2
Public Health
2
Public Hearing
2
Public Meetings
2
RICO
2
SEC
2
Standing
2
Summary Judgment
2
Takeda Pharmaceuticals
2
Third-Party
2
Trademarks
2
Zofran
1
3D Printing
1
510(k) RTA
1
Administrative Procedure Act
1
Admissible Evidence
1
Adverse Events
1
Affordable Care Act
1
Agency Deference
1
Allergan Inc
1
Alzheimer's
1
Amazon
1
Amended Regulation
1
America Invents Act
1
Amicus Briefs
1
ANDA
1
Animal Drugs
1
Arbitration
1
Attorney Generals
1
Attorney-Client Privilege
1
Below-Cost Pricing
1
Benefit Plan Sponsors
1
Biologics
1
Biotechnology
1
Board of Directors
1
CA Supreme Court
1
Calculation of Damages
1
Cancer
1
Celebrity Endorsements
1
Center for Drug Evaluation and Research (CDER)
1
Cephalon
1
Certiorari
1
Chilling Effect
1
Citizen Petitions
1
Civil Conspiracy
1
Civil Monetary Penalty
1
Class Certification
1
Class Representatives
1
CLRA
1
Commercial Marketing
1
Common Law Claims
1
Communications Decency Act
1
Compelled Speech
1
Compensatory Damages
1
Conflicting Proposals
1
Contract Drafting
1
COPPA
1
Copyright
1
Corporate Criminal Fines
1
Corporate Officers
1
Criminal Investigations
1
Cybertheft
1
Data Brokers
1
Data Privacy
1
Data Protection
1
Data Security
1
Daubert Standards
1
De Novo Standard of Review
1
Declaratory Judgments
1
Defamation
1
Design Defects
1
Disclaimers
1
Discovery
1
Discovery Rule
1
Diversity Jurisdiction
1
DMEPOS
1
Do Not Disturb
1
Draft Guidance
1
Drug Approvals
1
Due Diligence
1
E-Cigarettes
1
Electronic Communications
1
Eleventh Amendment
1
Enforcement
1
EPA
1
ESPN
1
Ethics
1
Evidence Suppression
1
Ex Post Facto Clause
1
Facebook
1
Fair Notice
1
False Statements
1
FCC
1
Federal Contractors
1
Federal Question Jurisdiction
1
Federal v State Law Application
1
FERA
1
FFDCA
1
FIFRA
1
Fifth Amendment
1
Financial Services Authority
1
Food Labeling
1
Forfeiture Statutes
1
Former Employee
1
Fourteenth Amendment
1
Fraudulent Joinder
1
FRCP 23(b)(3)
1
FTC v Actavis
1
General Jurisdiction
1
Genetically Engineered Seed
1
Genuine Issue of Material Fact
1
Good Faith
1
Government Investigations
1
GRAS
1
Halliburton
1
Hatch-Waxman
1
Healthcare Facilities
1
Hearsay
1
Heightened Scrutiny
1
HIPAA
1
HRSA
1
Human Rights
1
Humana
1
Implied Certification
1
Implied Preemption
1
Implied Warranties
1
Indictments
1
Induced Infringement
1
Inducements
1
Informed Consent
1
Insider Trading
1
Instagram
1
Insurance Industry
1
International Arbitration
1
Interstate Commerce
1
Investigational New Drug Application (IND)
1
Ireland
1
Jury Verdicts
1
Kaplan
1
Kickbacks
1
Kim Kardashian
1
Learned Intermediary
1
Licenses
1
Lipitor
1
Marijuana
1
Mary Jo White
1
Mass Tort Litigation
1
Medical Expenses
1
Merck
1
Morgan Stanley
1
Motion to Dismiss
1
Motion to Remand
1
MySpace
1
Negligence Per Se
1
Negligent Infliction of Emotional Distress
1
Negligent Misrepresentation
1
Nexus
1
NLRA
1
Northern Ireland
1
Omnicare
1
Out-of-State Judgments
1
Overpayment
1
Par Pharmaceutical
1
Patent Infringement
1
Patent Litigation
1
Patent Reform
1
Payday Loans
1
Payor Contracts
1
Pending Legislation
1
Pensions
1
Personal Jurisdiction
1
Personal Liability
1
Personally Identifiable Information
1
Pesticides
1
Petition For Rehearing
1
Pfizer
1
Pharmaceutical Patents
1
PHRMA
1
Physician Medicare Reimbursements
1
Ponzi Scheme
1
Predominance Requirement
1
Prescription Drug Coverage
1
Prior User
1
Promissory Estoppel
1
Public Disclosure
1
Public Safety
1
Punitive Damages
1
Putative Class Actions
1
Reed v Town of Gilbert
1
Registration
1
Remand
1
Res Ipsa Loquitur
1
Retailers
1
Rule 23
1
Rule 26
1
Rule 9(b)
1
Schering-Plough
1
Scientific Evidence
1
Scientific Research
1
Search Warrant
1
Section 340B
1
Section 5
1
Securities Act of 1933
1
Self-Authentication
1
Settlement
1
Skinnygirl Margarita
1
Social Media
1
Sovereign Immunity
1
Split of Authority
1
Spoliation
1
Statute of Limitations
1
Statutory Immunity
1
Strict Liability
1
Subject Matter Jurisdiction
1
Subpoenas
1
TCPA
1
Technology
1
Testimony
1
The Common Rule
1
Third Party Funding
1
Tobacco
1
Tortious Interference
1
Transfer of Venue
1
Twitter
1
Twombly/Iqbal Pleading Standard
1
Unfair Competition
1
Unfair or Deceptive Trade Practices
1
USDA
1
Virtual Goods
1
Warning Labels
1
Wells Fargo
1
White Collar Crimes
1
Wire Fraud
1
Work Product Privilege
1
WSLA
1
Yates Memorandum
1
Young Lawyers
1
YouTube